Freestone Capital Holdings, LLC Athira Pharma, Inc. Transaction History
Freestone Capital Holdings, LLC
- $2.87 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ATHA
# of Institutions
64Shares Held
19MCall Options Held
23.6KPut Options Held
68K-
Perceptive Advisors LLC New York, NY5.4MShares$2.54 Million0.11% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.78MShares$1.3 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$731,6250.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$701,6120.05% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$701,6120.87% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $17.8M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...